SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-050953
Filing Date
2018-08-09
Accepted
2018-08-09 16:19:38
Documents
54
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-18204_110q.htm 10-Q 624110
2 EX-10.1 a18-18204_1ex10d1.htm EX-10.1 463884
3 EX-10.3 a18-18204_1ex10d3.htm EX-10.3 264462
4 EX-31.1 a18-18204_1ex31d1.htm EX-31.1 11841
5 EX-31.2 a18-18204_1ex31d2.htm EX-31.2 11864
6 EX-32.1 a18-18204_1ex32d1.htm EX-32.1 7916
13 GRAPHIC g182041ks09i001.jpg GRAPHIC 2551
14 GRAPHIC g182041ks11i001.jpg GRAPHIC 3189
15 GRAPHIC g182041ks11i002.gif GRAPHIC 150
16 GRAPHIC g182041ku11i001.jpg GRAPHIC 6382
  Complete submission text file 0001104659-18-050953.txt   4098979

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dova-20180630.xml EX-101.INS 513709
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dova-20180630.xsd EX-101.SCH 40091
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dova-20180630_cal.xml EX-101.CAL 34588
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT dova-20180630_lab.xml EX-101.LAB 396223
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dova-20180630_pre.xml EX-101.PRE 265810
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dova-20180630_def.xml EX-101.DEF 159258
Mailing Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713 919-806-4487
Dova Pharmaceuticals, Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38135 | Film No.: 181005313
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences